OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ZEALAND PHARMA A/S DK 1/  DK0060257814  /

Berlin
6/5/2024  9:43:11 PM Chg. +0.45 Volume Bid6/5/2024 Ask6/5/2024 High Low
82.85EUR +0.55% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 83.10 81.90
GlobeNewswire 5/31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 5/29 Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
GlobeNewswire 5/23 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low ...
GlobeNewswire 5/16 Zealand Pharma Announces Financial Results for the First Quarter of 2024
GlobeNewswire 5/9 Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial...
GlobeNewswire 3/20 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatm...
GlobeNewswire 3/1 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
GlobeNewswire 2/27 Zealand Pharma Announces Financial Results for the Full Year 2023
TeleTrader 2/26 Zealand Pharma soars 30% on positive weight-loss drug results
GlobeNewswire 2/26 Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated ...
GlobeNewswire 2/26 Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver dise...
GlobeNewswire 2/20 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financia...
GlobeNewswire 1/19 Zealand Pharma major shareholder announcement: J O Hambro Capital Management
GlobeNewswire 1/17 Zealand Pharma major shareholder announcement: J O Hambro Capital Management
GlobeNewswire 1/12 Zealand Pharma completes registration of capital increase
GlobeNewswire 1/10 Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
GlobeNewswire 1/8 Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion
GlobeNewswire 1/2 Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on Janua...
GlobeNewswire 12/23/2023 U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyp...
GlobeNewswire 12/22/2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
GlobeNewswire 12/22/2023 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 12/4/2023 Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
GlobeNewswire 11/30/2023 Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
GlobeNewswire 11/9/2023 Zealand Pharma Announces Financial Results for the First Nine Months of 2023
GlobeNewswire 11/7/2023 Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023